An announcement from Allarity Therapeutics, Inc. (ALLR) is now available.
Allarity Therapeutics, Inc. announced it expects to regain compliance with Nasdaq’s Stockholders’ Equity Requirement after determining its stockholder equity exceeds the minimum $2.5 million threshold. The company is now awaiting Nasdaq’s decision on its compliance status. Separately, Allarity has also withdrawn its Registration Statement on Form S-1, initially filed in October 2023, as indicated in a recent press release.
For a thorough assessment of ALLR stock, go to TipRanks’ Stock Analysis page.
